BioHarvest Sciences Inc. (CNVCF)
BioHarvest Sciences Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $6.30, giving a market capitalisation of $109.2M. On trailing twelve-month figures it carries a trailing P/E of -7.14, a net margin of -51.3%. Its beta of 1.49 implies it has historically moved more than the broad market.
BioHarvest Sciences Inc., along with its subsidiaries, supplies a range of nutraceutical products and medical cannabis to customers both in Israel and globally. The company leverages an innovative plant cell growth technology that allows it to cultivate active secondary metabolites directly from cells, completely circumventing the need to grow the actual plant. BioHarvest is responsible for the entire process, from designing and developing to manufacturing and marketing its offerings. These include Vinia, a nutraceutical powder derived from red grapes, as well as its medical cannabis line. The firm's main operational base is located in Vancouver, Canada.
BioHarvest Sciences Inc. is most often compared with the following Healthcare names: